EVOKE PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
EVOKE PHARMA, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 530.08 thousand shares as of 2015-12-31, per its 10-K filed 2016-03-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2016-03-10
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 530.08K shares.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 259.08K shares.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 90.54K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2015-12-31 | 530.08K shares 10-K · filed 2016-03-10 |
| 2014-12-31 | 259.08K shares 10-K · filed 2015-03-04 |
| 2013-12-31 | 90.54K shares 10-K · filed 2014-03-25 |